Understanding VEP P100 Latency in Multiple Sclerosis Pathology

Clinicians have long recognized visual evoked potential assessments as pivotal diagnostic tools in neuroimmunology. Specifically, measuring VEP P100 latency provides an objective window into the functional integrity of anterior visual pathways. In people with multiple sclerosis, demyelinating lesions along the optic nerves decelerate saltatory conduction. Consequently, electrical impulses originating at the retinal photoreceptors experience substantial arrival delays at the primary visual cortex. The resulting prolongation of the positive deflection at approximately one hundred milliseconds reflects acute or chronic inflammatory myelin disruption. However, conventional clinical neurophysiology historically interpreted these latency shifts merely as focal signs of optic neuritis or local demyelination. Practitioners frequently debated whether electrical conduction delays capture only localized anterior pathology or indicate broader cerebral changes. Furthermore, emerging pathophysiological evidence demonstrates that central nervous system inflammation rarely occurs in complete isolation. Diffuse axonal transection and insidious microstructural degradation accompany focal inflammatory plaques across multiple functional tracts. Therefore, investigating whether electrophysiological slowing reflects generalized tissue injury represents an urgent clinical priority. Understanding these widespread associations helps clinicians better contextualize subtle neurophysiological deficits observed during routine clinical reviews.

Disentangling Retinal Changes from Central Neurodegeneration

Modern neuro-ophthalmological evaluations often combine functional electrophysiology with high-resolution structural imaging. Specifically, spectral-domain optical coherence tomography reliably measures peripapillary retinal nerve fiber layer thickness. Because the retina lacks myelin, retinal nerve fiber thinning directly reflects unmyelinated axonal degeneration. However, clinicians often face complex interpretive challenges when evaluating visual pathway damage. Demyelination in the retrobulbar optic nerve causes retrograde axonal loss that eventually affects retinal layers. Conversely, primary retinal damage can alter subsequent electrical signal transmission through the optic chiasm and optic radiations. Consequently, researchers needed a rigorous analytical framework to disentangle upstream retinal degradation from downstream central neurodegenerative changes. Age-related cerebral atrophy also introduces substantial confounding during neuroimaging assessments. In addition, chronic demyelination may independently progress alongside diffuse cortical atrophy and normal aging processes. Therefore, statistical mediation models are vital to isolate the unique pathophysiological contribution of visual pathway delays. By controlling for retinal fiber thinning and chronological age, investigators can determine whether conduction slowing directly correlates with whole-brain tissue destruction. Resolving this question clarifies whether routine evoked potentials deliver clinical value far beyond basic optic nerve evaluation.

Study Design: Multimodal Integration of OCT, VEP, and MRI Metrics

A recent cross-sectional investigation evaluated sixty-four individuals diagnosed with multiple sclerosis to address this crucial clinical dilemma. First, participants completed comprehensive optical coherence tomography scanning using specialized Heidelberg Spectralis hardware. This diagnostic technology provided exact measurements of peripapillary retinal nerve fiber layer thickness across all quadrants. Next, standardized neurophysiological assessments captured monocular visual evoked potential latencies for each participant eye. Investigators meticulously recorded the precise latency of the P100 wave to quantify electrical transmission delays. In addition, all participants completed volumetric brain magnetic resonance imaging on standardized high-field scanners. Neuroimaging analysts determined whole brain volume, gray matter volume, and T2-FLAIR hyperintense lesion volume using automated segmentation software. To evaluate real associations, researchers applied multivariable linear mediation analyses to the integrated clinical dataset. These statistical models systematically adjusted for mediating effects from retinal nerve fiber thickness and chronological age. Consequently, the research design effectively eliminated confounding variance caused by localized anterior axonal loss or natural senescence. Through this multimodal framework, the investigators successfully isolated direct neurodegenerative correlates of central visual pathway slowing.

Significant Correlations with Cerebral Atrophy and Lesion Burden

The statistical mediation analyses revealed remarkable connections between visual electrophysiology and magnetic resonance imaging parameters. Most notably, prolonged P100 latency significantly correlated with lower whole brain volume. Statistical models demonstrated that 87.8% of this total detrimental effect occurred directly and independently from retinal nerve fiber thickness. Furthermore, this relationship remained highly robust after controlling for the significant covariate influence of participant age. Greater transmission delay was similarly predictive of reduced cortical gray matter volume with pronounced statistical significance. In addition, longer latencies demonstrated an independent direct relationship with higher T2-FLAIR lesion volume across the cohort. These findings confirm that electrical conduction delays do not merely echo anterior retinal axonal loss. Instead, prolonged latency reflects severe downstream central nervous system injury throughout interconnected cerebral white and gray matter compartments. Persistent neuroinflammation and chronic demyelination disrupt synchronization across long-range white matter tracts. Accordingly, severe latency prolongation parallels accelerated tissue loss and expansive demyelinating plaque accumulation. This evidence positions electrophysiological slowing as a potent indicator of diffuse neuroaxonal depletion in patients with multiple sclerosis.

Neurobiological Mechanisms: Why Conduction Delays Reflect Global Neurodegeneration

Understanding the biological link between visual electrophysiology and global cerebral volume requires examining central nervous system connectivity. The visual pathway spans extensive anatomical territory, traveling from retinal ganglion cells to the calcarine cortex. Demyelination along this pathway causes saltatory conduction failure, which increases metabolic stress on denuded axons. Consequently, chronically demyelinated axons undergo energy failure, mitochondrial exhaustion, and subsequent structural transection. Moreover, retrograde and trans-synaptic anterograde degenerations propagate pathological stress into subcortical relay centers, including the lateral geniculate nucleus. Pathologists also observe diffuse microglial activation and meningeal inflammation driving progressive subpial cortical demyelination. Thus, prolonged latency serves as a sentinel functional marker for widespread microscopic neuroinflammation and progressive axonal attrition. Even when overt clinical relapses subside, silent neurodegeneration continues to dismantle cerebral architecture beneath the surface. Volumetric magnetic resonance imaging detects this relentless destruction as measurable brain atrophy and accumulating lesion volume. Meanwhile, neurophysiological testing dynamically captures the functional consequences of this widespread structural disintegration in real time. Ultimately, visual conduction latency bridges the gap between focal electrophysiological disturbances and systemic central nervous system neurodegeneration.

Translating Electrophysiological Markers into MS Clinical Practice

These compelling findings provide valuable practical insights for clinical neurologists, ophthalmologists, and radiologists managing multiple sclerosis. Routine monitoring often relies exclusively on physical disability scales and periodic neuroimaging scans. However, volumetric magnetic resonance software is not universally accessible across all outpatient centers in clinical settings. Furthermore, standard magnetic resonance scans sometimes fail to detect early functional deterioration preceding macrostructural volume loss. Incorporating visual evoked potential latency testing offers an accessible, cost-effective, and highly reproducible neurophysiological metric. Clinicians can utilize prolonged latencies to identify patients at heightened risk of rapid gray matter atrophy. Moreover, tracking conduction velocity changes provides objective endpoints during clinical trials assessing novel neuroprotective or remyelinating compounds. Early detection of functional decline empowers clinicians to optimize disease-modifying therapies before irreversible neurological disability solidifies. In addition, combining electrophysiological evaluations with optical coherence tomography establishes a comprehensive, multimodal paradigm for longitudinal patient surveillance. As precision medicine transforms neuroimmunology, integrating electrophysiological markers into holistic assessment protocols will significantly enhance clinical decision-making. Therefore, neurophysiologists must recognize visual evoked potential prolongation as an informative herald of widespread cerebral neurodegeneration.

Frequently Asked Questions

What causes prolonged VEP P100 latency in multiple sclerosis?

Demyelinating lesions along the anterior visual pathway disrupt the protective myelin sheaths surrounding axons. This damage impairs rapid saltatory conduction, significantly slowing action potential propagation from retinal ganglion cells to the visual cortex. Consequently, the positive electrical potential arrives late, manifesting as an extended P100 latency during neurophysiological recording.

How does optical coherence tomography complement visual evoked potentials?

Optical coherence tomography provides high-resolution cross-sectional visualization of retinal structural morphology, measuring retinal nerve fiber layer thickness. In contrast, visual evoked potentials quantify functional electrophysiological conduction speed across entire visual pathways. Combining both modalities enables clinicians to differentiate localized retinal structural loss from progressive central demyelination and downstream cerebral atrophy.

Can VEP latency help monitor progressive neurodegeneration in clinical practice?

Yes, visual evoked potential latency serves as an objective functional biomarker for progressive neuroaxonal loss. Because conduction delays correlate directly with lower whole brain volume and gray matter atrophy independently of age, serial latency measurements provide clinicians with dynamic insights into hidden central neurodegeneration, guiding therapy escalation decisions.

Disclaimer: This content is for informational and educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.

References

• Jakimovski D et al. VEP latency delays predicts MRI neurodegenerative outcomes in multiple sclerosis. J Neurol. 2026 Sep 25. doi: 10.1007/s00415-026-14151-y. PMID: 42788996.


• Leocani L, Guerrieri S, Comi G. Visual evoked potentials in multiple sclerosis: P100 latency and visual pathway damage including the lateral geniculate nucleus. Clin Neurophysiol. 2024;162:10-18.


• Petzold A, de Seze J, Balk L, et al. Visually Evoked Potential as Prognostic Biomarker for Neuroaxonal Damage in Multiple Sclerosis From a Multicenter Longitudinal Cohort. Neurol Neuroimmunol Neuroinflamm. 2023;10(3):e200096.